PART I . Overview We are a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases. Our proprietary AIDE technology platform is an innovative drug/device combination that uses an automated process designed to encapsulate a drug into the patients own red blood cells. Red blood cells have several characteristics that make them an excellent vehicle for drug delivery, potentially including better safety and tolerability, enhanced...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-24 | 2024-12-31 | 0001662774-25-000012 | EDGAR | 102K words |
| 2024-04-01 | 2023-12-31 | 0000950170-24-039440 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0000950170-23-008148 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002571 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001564590-21-009867 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001564590-20-011165 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001193125-26-352201 | EDGAR | — |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277529 | EDGAR | 30K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106535 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001662774-25-000032 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001662774-24-000011 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001662774-24-000005 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058201 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063716 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-038042 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-022241 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023877 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016102 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-17 | 0001193125-26-353141 | EDGAR | — |
| 2026-08-14 | 0001193125-26-350568 | EDGAR | — |
| 2026-07-31 | 0001193125-26-328784 | EDGAR | — |
| 2026-03-30 | 0001193125-26-130489 | EDGAR | 1K words |
| 2026-03-20 | 0001193125-26-117794 | EDGAR | — |
| 2026-02-12 | 0001193125-26-047544 | EDGAR | — |
| 2026-02-02 | 0001193125-26-033758 | EDGAR | — |
| 2026-01-29 | 0001193125-26-029524 | EDGAR | — |
| 2025-11-12 | 0001193125-25-277523 | EDGAR | — |
| 2025-10-17 | 0001193125-25-242514 | EDGAR | — |
114 total filings indexed. 86 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001662774 |
| Ticker | QNCX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | CA |
| Website | https://www.quincetx.com |
| Listed | 2019-05-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/QNCX (~200 tokens, structured JSON with cryptographic provenance)